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Abstract: Here we report a case of successful fiber optic laser treatment of lymphedema in a 
swollen arm post mastectomy. At the moment, this procedure has only anecdotal evidence to 
 justify its use, but in our experience is a feasible, minimally invasive day-stay procedure which has 
been demonstrated to be safe and effective. Further nonhomogeneous case pooling and follow-up 
would enable guidelines and definite surgical protocols for its use to be implemented.
Keywords: fiber optic, lymphedema, Nd:YAG, laser, mastectomy
Introduction
Fiber optic laser surgery has been successfully introduced in several medical fields, 
especially in the oncological area.1–5 In angiology, intravenous laser therapy is a dedi-
cated venous procedure which can be used to remove an occlusion in the lumen of 
the saphenous system.6 Over the last 3 years, we have gained considerable confidence 
in fiber optic technology, and have recently started to use this technique to assist in 
drainage of interstitial fluid to prevent fibrosis in patients with breast-cancer-related 
lymphedema.7 Furthermore, a previous study used gallium arsenide (GaAs) laser 
therapy in postmastectomy patients, resulting in limb volume reduction and increases 
in shoulder mobility and grip strength.8 Keeping the fiber optic laser positioned in a 
150 µm cavity under the skin, the laser is then rotated upwards and activated to produce 
a series of short radial 10–15 cm tunnels within the normal lymphatic network in the 
skin, with the aim of diverting the volume of pooled interstitial fluid cephalad, redis-
tributing the fluid in different directions by pressotherapy,9 and inducing reabsorption of 
the fluid into the lymphatic vessels (Figure 1). The procedure can be performed under 
local anesthesia with or without simple sedation, and with the aid of a skin cooling 
system.10 Because it is an office or day-surgery procedure, it should not require any 
theatre time or prolonged hospital stay.
Case report
Twelve months ago, a 77-year-old woman, who had had a partial right mastectomy 
(biquadrantectomy) and lymphadenectomy for metastatic cancer, presented with progres-
sive lymphedema of her right arm and an erysipelatous infection which was immediately 
treated with an aggressive combination regimen of teicoplanin (Targosid, 200 mg; 
Sanofi-Aventis, Milan, Italy) and vancomycin (Vancomicina Hikma, 250 mg; Hikma 
Italia, Pavia, Italy). The patient underwent rehabilitation consisting of overnight elastic 
 support with regular active and passive muscle exercise during the day. The patient’s arm 
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circumference measurements at presentation are reported in 
Table 1. The patient signed an informed consent explaining 
the laser procedure in detail and its potential complications. 
She agreed to undergo laser treatment in view of progressive 
hardening and stiffening of her finger, wrist, and elbow. The 
procedure was performed in accordance with the tenets of 
the Declaration of Helsinki. Internal review board approval 
was obtained.
A 1062 nm 15 W Nd:YAG system (Evlaser®, Elettronica 
Valseriana, Casnigo, Italy) was used. It was connected to a 
150 µm diameter and 1 m long sterile fiber optic. Tramadol 
(Unitrama, 100 mg capsules;  Angelini, Rome, Italy) and 
ketoprofen (Artrosilene, 160 mg/2 mL injectable solution; 
Dompé, L’Aquila, Italy) were administered by an intravenous 
line at the beginning of treatment, with an assistant cooling 
the arm using a frozen 10 cm2 diameter plate. A bolus of 2% 
lidocaine (Lidocaina 100 mg/5 mL; Angelini) was injected 
to anesthetize the 2 cm2 area of skin selected to introduce 
the fiber optic laser. Skin perforation was performed using 
a 21-gauge plastic venous catheter bearing a stainless steel 
stylet to aid  introduction. Next, the stylet was withdrawn 
and the fiber optic laser was introduced into the lumen and 
advanced forward with its tip continuously emitting 150 J/cm2 
to perforate the fibrous tissue and create a channel during 
advancement along the entire length of her arm (Figure 2). 
At the end of the procedure, the fiber optic tip was retrieved 
via the incision in the skin and redirected subdermally 
upwards into the normal lymphatic network, advanced for 
a shorter length (15–20 cm) in multiple radial directions 
to create shorter (15–30) tunnels where the lymph, which 
had been pushed upwards, could be temporarily pooled and 
then absorbed via the normal lymphatic network. The time 
taken to complete the procedure was about 1.5 hours. No 
stitches were required at the laser access site, and an elastic 
bandage was applied for 24 hours postoperatively. At 10-day 
follow-up, a decrease of arm and forearm circumference was 
observed (Figure 3; Table 1). The procedure was repeated 2 
weeks later in previously untreated regions of her right arm 
using the same protocol to achieve further volume reduction 
(Figure 3) and thereby improve her arm function. After the 
second session, the patient’s range of movement at her fingers, 
wrist, and elbow had improved.
Four month follow-up showed partial relapse of the 
treated segments consistent with hardness and stiffness. No 
further decrease in right arm circumference was observed, 
but the patient did not revert to her original clinical condi-
tion and asked for a third laser procedure because of the 
pain-free nature and low invasiveness of the method. After 
the procedure, the patient underwent three daily 30-minute 
sessions of manual lymph drainage and home pressotherapy 
twice daily for a week.
Discussion
This is the first report of the feasibility and safety of a novel 
procedure to reduce lymphedema using fiber optic laser to 
drill new channels for lymphatic drainage. In our experi-
ence, the procedure can be repeated up to 5–10 times in 6 
months, depending on the patient’s connective tissue reac-
tion. Lymph drainage by manual massage and pressotherapy 
helps the drilled tunnels to become engorged with interstitial 
fluid and improves their patency, which counteracts occlusion 
by exceeding the outer-inner pressure ratio. The procedure 
described in this article is painless, if local anesthesia is 
A B
C D
Figure 1 (A) Radial short tunnels along the right upper arm. (B and C) Nd:YAG 
laser device and operating settings. (D) Introduction of the fiber optic laser through 
an incision in the skin, along with the skin cooling system.
Table 1 Patient’s upper limb circumference measurements before and after first and second treatment
Right arm Left arm Right forearm Left forearm Right wrist Left wrist
First treatment 36 cm 30 cm 33 cm 26 cm 22 cm 19 cm
First follow-up (10 days) 34 cm 30 cm 31 cm 26 cm 22 cm 19 cm
Second treatment 34 cm 30 cm 31 cm 26 cm 20 cm 19 cm
Second follow-up (4 months)34 cm 30 cm 30 cm 26 cm 20 cm 19 cm
Note: Partial relapse of treated segments  observed  after second follow-up.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
86
Palmieri et al
OncoTargets and Therapy 2013:6
fact, in our experience, it is very easy to drill the fibrotic septa 
that trap interstitial fluid in lymphedema by laser energy, 
but these passive newly formed lumina are prone to further 
fibrosis and obliteration. Therefore, our future goal will be to 
seed a layer of autologous endothelial cells recovered from 
short-segment phlebectomy into the newly formed chan-
nels or inject bone marrow-derived mesothelial stem cells 
to form a new endothelial surface, mimicking the patency 
and function of the normal lymphatic network.13 Our fiber 
optic laser channel drilling approach with moderate beam 
power (150 J/cm2) is very effective for rapid perforation of 
fibrous strands of lymphedematous tissue, without exces-
sive  heating or burning adjacent structures. In particular, 
when the fiber optic is withdrawn at the end of treatment, 
the interstitial fluid becomes cooler quickly since it is forced 
to diffuse into the new channels created by the laser. Active 
and passive rehabilitation exercise promotes continuous 
lymph flow into these structures, prolongs their patency and 
viability, and may be very efficacious if antifibrotic treatment 
is administered at the same time.14
Conclusion
Treatment of lymphedema using f iber optic laser is 
now a promising candidate treatment for helping presso-
therapy rehabilitation to improve function and  quality of life 
in patients affected by lymphedema. 
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used at the skin access site and the arm surface is regularly 
cooled.11 Obviously, multiple longitudinal channel drilling 
cannot be considered a radical management procedure for 
lymphedema. Because it achieves autonomous active lym-
phatic drainage, regular daily mechanical or manual pres-
sotherapy9 is required to keep the channels open and prevent 
further fibrotic reactions and obstruction of continuous 
lymph flow into the newly formed lumen. In our experience, 
it is mandatory to prepare a functional area in the normal 
dermis cephalad to the lymphedematous tissue in order to 
distribute the drained lymphatic volume recovered by daily 
pressotherapy through these short (15–20 cm) newly formed 
channels. Even if this step may damage the normal lymphatic 
network in the adjacent area,12 it is necessary in order to 
facilitate uptake of fluid into normal lymphatic  vessels. In 
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